These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 197423)

  • 61. A simple approach to study the effect of haloperidol on GABA functional activity in the nigro-striatal system.
    Cattabeni F; Maggi A; DeAngelis L; Bruno F; Racagni G
    J Neurochem; 1977 Jun; 28(6):1407-8. PubMed ID: 874507
    [No Abstract]   [Full Text] [Related]  

  • 62. Release of [3H] GABA from rat cortical slices: neuronal vs glial origin.
    Hammerstad JP; Lytle CR
    J Neurochem; 1976 Aug; 27(2):399-403. PubMed ID: 965982
    [No Abstract]   [Full Text] [Related]  

  • 63. Hyperosmolality-induced GABA release from rat brain slices: studies of calcium dependency and sources of release.
    Chan PH; Wong YP; Fishman RA
    J Neurochem; 1978 Jun; 30(6):1363-8. PubMed ID: 670978
    [No Abstract]   [Full Text] [Related]  

  • 64. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study.
    Hoffman AF; Gerhardt GA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):455-63. PubMed ID: 10087038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 66. Release and exchange studies relating to the synaptosomal uptake of GABA.
    Raiteri M; Federico R; Coletti A; Levi G
    J Neurochem; 1975 Jun; 24(6):1243-50. PubMed ID: 1127436
    [No Abstract]   [Full Text] [Related]  

  • 67. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra.
    Innis RB; Aghajanian GK
    Brain Res; 1987 May; 411(1):139-43. PubMed ID: 2955848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition by ruthenium red of the calcium-dependent release of [3H]GABA in synaptosomal fractions.
    Tapia R; Meza-Ruíz G
    Brain Res; 1977 Apr; 126(1):160-6. PubMed ID: 851889
    [No Abstract]   [Full Text] [Related]  

  • 70. The effects of antipsychotics on the turnover rate of GABA and acetylcholine in rat brain nuclei.
    Marco E; Mao CC; Cheney DL; Revuelta A; Costa E
    Nature; 1976 Nov; 264(5584):363-5. PubMed ID: 12475
    [No Abstract]   [Full Text] [Related]  

  • 71. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dopamine may influence striatal GABA release via three separate mechanisms.
    Bernath S; Zigmond MJ
    Brain Res; 1989 Jan; 476(2):373-6. PubMed ID: 2649207
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vivo release of endogenous GABA from rat substantia nigra measured by a novel method.
    Van der Heyden JA; Venema K; Korf J
    J Neurochem; 1979 Feb; 32(2):469-76. PubMed ID: 762559
    [No Abstract]   [Full Text] [Related]  

  • 74. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.
    Lacey MG; Mercuri NB; North RA
    J Physiol; 1987 Nov; 392():397-416. PubMed ID: 2451725
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Glycine release in the substantia nigra: Interaction with glutamate and GABA.
    Dopico JG; González-Hernández T; Pérez IM; García IG; Abril AM; Inchausti JO; Rodríguez Díaz M
    Neuropharmacology; 2006 Apr; 50(5):548-57. PubMed ID: 16337663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of substance P and SP(1-7) on dopamine release from rat substantia nigra.
    Hall ME; Nockels C; Stewart JM
    Ann N Y Acad Sci; 1991; 632():407-9. PubMed ID: 1719889
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of alpha-flupenthixol on dopamine and 5-hydroxytryptamine responses of substantia nigra neurones.
    Dray A; Gonye TJ; Oakley NR
    Neuropharmacology; 1976 Dec; 15(12):793-6. PubMed ID: 1012444
    [No Abstract]   [Full Text] [Related]  

  • 79. Localization of opiate receptors in substantia nigra evidence by lesion studies.
    Llorens-Cortes C; Pollard H; Schwartz JC
    Neurosci Lett; 1979 May; 12(2-3):165-70. PubMed ID: 223090
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro release of 5-[3H]hydroxytryptamine from rat spinal trigeminal nucleus.
    Reubi JC
    Neurosci Lett; 1980 Mar; 16(3):263-7. PubMed ID: 6189005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.